MindBio Therapeutics Corp., a biotechnology company focused on AI-driven voice analytics for intoxication detection, announced the completion of its Intox Collect technology. The platform enables rapid scaling of data collection and analysis across a wide range of substances using voice and facial recognition. This development enhances the company's ability to train its AI model, which leverages more than 50 million data points to predict drug and alcohol intoxication through voice with high accuracy.
The technology supports expansion into regulated industries such as mining, aviation, and construction. The company is advancing toward commercialization with upcoming Edge AI kiosk devices expected to begin testing in the second quarter of 2026. These kiosks will integrate bespoke hardware and software for detecting drug and alcohol intoxication using human voice and AI in various enterprise environments.
MindBio's AI prediction model uses over 50 million data points to predict alcohol intoxication with remarkable accuracy through voice analysis alone. The completion of Intox Collect represents a significant step in the company's commercialisation efforts for AI prediction technologies in intoxication detection. The platform's ability to rapidly scale data collection and analysis positions the company to address safety concerns in high-risk industries where intoxication detection is critical.
The technology announcement comes as MindBio prepares for broader implementation of its systems. The Edge AI kiosks represent a tangible application of the company's research and development efforts. More information about the company's developments is available through its newsroom at https://ibn.fm/MBQIF. The full press release detailing this technological advancement can be accessed at https://ibn.fm/8v5XE.
